Medigus Ltd Sponsored ADR Stock

$3.79

5.37%

Nasdaq, Fri, Sep 13 2024

ISIN

US58471G2012

Symbol

MDGS

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Medigus Ltd Sponsored ADR Stock price

$3.79

-75.02 95.20% 5Y

Nasdaq, Closing price Fri, Sep 13 2024

-0.21 5.37%

ISIN

US58471G2012

Symbol

MDGS

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Market capitalization	$2.65m
Enterprise Value	$9.56m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	0.10
P/S ratio (TTM) P/S ratio	0.03
P/B ratio (TTM) P/B ratio	0.11
Revenue growth (TTM) Revenue growth	-0.63%
Revenue (TTM) Revenue	$92.70m
EBIT (operating result TTM) EBIT	$-10.97m
Free Cash Flow (TTM) Free Cash Flow	$-6.46m
EPS (TTM) EPS	$-25.65
P/S forward	0.03
EV/Sales forward	0.09
Short interest	0.22%

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Get Started for Free Today

Medigus Ltd Sponsored ADR Stock Analysis

Unlock Scores for Free

??

1 Analyst has issued a forecast Medigus Ltd Sponsored ADR:

1x Buy

100%

More details on Analyst Estimates Including Price Targets

1 Analyst has issued a forecast Medigus Ltd Sponsored ADR:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Medigus Ltd Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

TTM Annually

Dec '23		+/- %
Revenue	93 93	1% 1% 100%
- Direct Costs	81 81	3% 3% 87%
Gross Profit	12 12	19% 19% 13%
- Selling and Administrative Expenses	13 13	15% 15% 14%
- Research and Development Expense	5.97 5.97	21% 21% 6%
EBITDA	-6.94 -6.94	27% 27% -7%
- Depreciation and Amortization	4.03 4.03	25% 25% 4%
EBIT (Operating Income) EBIT	-11 -11	26% 26% -12%
Net Profit	-16 -16	63% 63% -17%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Medigus Ltd Sponsored ADR Stock News

Neutral

GlobeNewsWire

●

about one month ago

Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems

TEL AVIV, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that ParaZero Technologies Ltd. (Nasdaq: PRZO) ( “ParaZero”), an aerospace company focused on drone safety systems for defense and commercial drones and urban air mobility aircraft (18.68% own...

Neutral

GlobeNewsWire

●

about 2 months ago

Xylo Technologies Announces Plan to Implement ADS Ratio Change

Tel Aviv, Israel, July 30, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” and the “Company”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that it plans a ratio change which will result in a reverse split of the Company's American Depositary Receipt, or ADR...

Neutral

GlobeNewsWire

●

about 2 months ago

Xylo Technologies: Charging Robotics Lands Commercial Order for EV Wireless Charging Systems in Automatic Car Parks

TEL AVIV, Israel, July 23, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo”, and the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that Charging Robotics, Inc. (OTC: CHEV) (“Charging Robotics”), an innovator of wireless charging solutions held 67% by Xylo, received its first commercial order for the deployment of its wi...

More Medigus Ltd Sponsored ADR News

Company Profile

Medigus Ltd. is a medical device company, which engages in the research and development, manufacture, and sale of endosurgical tools and instruments. It specializes in the area of Gastroesophageal reflux disease. Its product MUSE System offers minimal invasive endoscopic devices and procedures for gastric surgery. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Omer, Israel.

Head office	Israel
CEO	Liron Carmel
Employees	84
Founded	1999
Website	www.medigus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now